Market revenue in 2023 | USD 190,582.0 million |
Market revenue in 2030 | USD 410,151.1 million |
Growth rate | 11.6% (CAGR from 2023 to 2030) |
Largest segment | Drug delivery |
Fastest growing segment | Therapeutics |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Delivery, Therapeutics, In-vitro Diagnostics, Implants, In-vivo Imaging |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nanomedicine market will help companies and investors design strategic landscapes.
drug delivery was the largest segment with a revenue share of 34.13% in 2023. Horizon Databook has segmented the Global nanomedicine market based on drug delivery, therapeutics, in-vitro diagnostics, implants, in-vivo imaging covering the revenue growth of each sub-segment from 2018 to 2030.
Increase in the penetration of therapeutics segment in the nanomedicine market is attributive to the rising usage of the nanotechnology in drug delivery methods. Advancements with respect to nanorobotics, which is although in the nascent stage of development holds significant potential for growth in this market.
Involvement of scientists for engineering the nanorobots for the targeting and destruction of malignant cells in the cancer patients without affecting the surrounding healthy cells is expected to support product developments in the market. Moreover, use of DNA origami for building of nano scale robots which can interact dynamically and operate through logical computations is anticipated to poise investments from technologically established players.
Henceforth, these technological breakthroughs are expected to fuel progress in the nanotechnology market. Additionally, use of photoactive nanomaterials for improvement in the targeted delivery for photodynamic therapy coupled with development of micelles and emulsions and a diverse set of nanoparticles, gold particles or polymeric particles to reduce the toxicity of harmful compounds used in oncology is attributive for the industrial growth.
Horizon Databook provides a detailed overview of global-level data and insights on the Global nanomedicine market , including forecasts for subscribers. This global databook contains high-level insights into Global nanomedicine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related industry reports found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account